Karen S. Rommelfanger, Ph.D. - Publications

Emory University, Atlanta, GA 

17/27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Vadodaria KC, Yanpallewar SU, Vadhvani M, Toshniwal D, Liles LC, Rommelfanger KS, Weinshenker D, Vaidya VA. Noradrenergic regulation of plasticity marker expression in the adult rodent piriform cortex. Neuroscience Letters. PMID 28237805 DOI: 10.1016/j.neulet.2017.02.060  1
2015 Purcell RH, Rommelfanger KS. Internet-based brain training games, citizen scientists, and big data: ethical issues in unprecedented virtual territories. Neuron. 86: 356-9. PMID 25905809 DOI: 10.1016/j.neuron.2015.03.044  1
2015 Rommelfanger KS, Johnson LSM. What Lies Ahead for Neuroethics Scholarship and Education in Light of the Human Brain Projects? Ajob Neuroscience. 6: 1-3. DOI: 10.1080/21507740.2015.1000158  1
2014 Galvan A, Hu X, Rommelfanger KS, Pare JF, Khan ZU, Smith Y, Wichmann T. Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys. Journal of Neurophysiology. 112: 467-79. PMID 24760789 DOI: 10.1152/jn.00849.2013  1
2014 Trimper JB, Wolpe PR, Rommelfanger KS. When "I" becomes "We": ethical implications of emerging brain-to-brain interfacing technologies. Frontiers in Neuroengineering. 7: 4. PMID 24575002 DOI: 10.3389/fneng.2014.00004  1
2014 Meltzer CC, Sze G, Rommelfanger KS, Kinlaw K, Banja JD, Wolpe PR. Guidelines for the ethical use of neuroimages in medical testimony: report of a multidisciplinary consensus conference. Ajnr. American Journal of Neuroradiology. 35: 632-7. PMID 23988754 DOI: 10.3174/ajnr.A3711  1
2013 Rommelfanger KS. Opinion: A role for placebo therapy in psychogenic movement disorders. Nature Reviews. Neurology. 9: 351-6. PMID 23628738 DOI: 10.1038/nrneurol.2013.65  1
2013 Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, Rommelfanger KS, Schroeder JP, Stoll M, Schultze J, Weinshenker D, Heneka MT. Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biological Psychiatry. 73: 454-63. PMID 22883210 DOI: 10.1016/j.biopsych.2012.06.013  1
2013 Rommelfanger KS. Attitudes on Mind Over Matter: Physician Views on the Role of Placebo in Psychogenic Disorders Ajob Neuroscience. 4: 9-15. DOI: 10.1080/21507740.2013.796327  1
2012 Hadipour-Niktarash A, Rommelfanger KS, Masilamoni GJ, Smith Y, Wichmann T. Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys. Journal of Neurophysiology. 107: 1500-12. PMID 22131382 DOI: 10.1152/jn.00348.2011  1
2011 Rommelfanger KS, Boshears P. Ethical use of neuroscience Ajob Neuroscience. 2: 19-21. DOI: 10.1080/21507740.2011.559919  1
2010 Rommelfanger KS, Wichmann T. Extrastriatal dopaminergic circuits of the Basal Ganglia. Frontiers in Neuroanatomy. 4: 139. PMID 21103009 DOI: 10.3389/fnana.2010.00139  1
2010 Yanpallewar SU, Fernandes K, Marathe SV, Vadodaria KC, Jhaveri D, Rommelfanger K, Ladiwala U, Jha S, Muthig V, Hein L, Bartlett P, Weinshenker D, Vaidya VA. Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 1096-109. PMID 20089918 DOI: 10.1523/JNEUROSCI.2309-09.2010  1
2009 Rommelfanger KS, Mitrano DA, Smith Y, Weinshenker D. Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain. Neuroscience. 158: 1530-40. PMID 19068224 DOI: 10.1016/j.neuroscience.2008.11.019  1
2007 Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 13804-9. PMID 17702867 DOI: 10.1073/pnas.0702753104  1
2007 Rommelfanger KS, Weinshenker D. Norepinephrine: The redheaded stepchild of Parkinson's disease. Biochemical Pharmacology. 74: 177-90. PMID 17416354 DOI: 10.1016/j.bcp.2007.01.036  1
2004 Rommelfanger KS, Weinshenker D, Miller GW. Reduced MPTP toxicity in noradrenaline transporter knockout mice. Journal of Neurochemistry. 91: 1116-24. PMID 15569255 DOI: 10.1111/j.1471-4159.2004.02785.x  1
Low-probability matches
2019 Ahlgrim NS, Garza K, Hoffman C, Rommelfanger KS. Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health. Eneuro. PMID 31221862 DOI: 10.1523/ENEURO.0439-18.2019  0.01
2019 Ramos KM, Grady C, Greely HT, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS, Serrano EE, Churchill JD, Gordon JA, Koroshetz WJ. The NIH BRAIN Initiative: Integrating Neuroethics and Neuroscience. Neuron. 101: 394-398. PMID 30731065 DOI: 10.1016/j.neuron.2019.01.024  0.01
2019 Rommelfanger KS, Jeong SJ, Montojo C, Zirlinger M. Neuroethics: Think Global. Neuron. 101: 363-364. PMID 30731058 DOI: 10.1016/j.neuron.2019.01.041  0.01
2018 Ramos KM, Rommelfanger KS, Greely HT, Koroshetz WJ. Neuroethics and the NIH BRAIN Initiative. Journal of Responsible Innovation. 5: 122-130. PMID 30854409 DOI: 10.1080/23299460.2017.1319035  0.01
2018 Greely HT, Grady C, Ramos KM, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS, Serrano EE. Neuroethics Guiding Principles for the NIH BRAIN Initiative. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 38: 10586-10588. PMID 30541767 DOI: 10.1523/JNEUROSCI.2077-18.2018  0.01
2018 Rommelfanger KS, Jeong SJ, Ema A, Fukushi T, Kasai K, Ramos KM, Salles A, Singh I. Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives. Neuron. 100: 19-36. PMID 30308169 DOI: 10.1016/j.neuron.2018.09.021  0.01
2017 Wolpe PR, Rommelfanger KS. Ethical principles for the use of human cellular biotechnologies. Nature Biotechnology. 35: 1050-1058. PMID 29121024 DOI: 10.1038/nbt.4007  0.01
2017 Rommelfanger KS, Factor SA, LaRoche S, Rosen P, Young R, Rapaport MH. Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future. Frontiers in Neurology. 8: 106. PMID 28424653 DOI: 10.3389/fneur.2017.00106  0.01
2017 Purcell RH, Rommelfanger KS. Biometric Tracking From Professional Athletes to Consumers. The American Journal of Bioethics : Ajob. 17: 72-74. PMID 27996927 DOI: 10.1080/15265161.2016.1251652  0.01
2015 Sarrett JC, Rommelfanger KS. Commentary: Attention to Eyes Is Present but in Decline in 2-6-Month-Old Infants Later Diagnosed with Autism. Frontiers in Public Health. 3: 272. PMID 26697420 DOI: 10.3389/fpubh.2015.00272  0.01
Hide low-probability matches.